DNA

Q: What is the price of Ginkgo Bioworks Holdings (DNA) today?

The price of Ginkgo Bioworks Holdings (DNA) today is $ 9.34, with return of -0.95% compared to the last year. The price of Ginkgo Bioworks Holdings (DNA) started the year trading around $ 10.22 and today it is at $ 9.34. Follow the real-time price chart, the historical price of Ginkgo Bioworks Holdings (DNA) and international markets.

Q: When does Ginkgo Bioworks Holdings (DNA) pay dividends?

Ginkgo Bioworks Holdings (DNA) did not distribute dividends in the last year.

Q: Is Ginkgo Bioworks Holdings (DNA) worth it?

Currently, Ginkgo Bioworks Holdings (DNA) is priced at $ 9.34, with a P/E of -1.53%, representing a deviation of -152,271% from its historical average P/E. In the last year, the stock showed a variation of -0.95 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -0.95%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Ginkgo Bioworks Holdings (DNA) stock?

Investing in stocks of Ginkgo Bioworks Holdings (DNA) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Ginkgo Bioworks Holdings (DNA) yield today?

The yield of Ginkgo Bioworks Holdings (DNA) was 16.75% in the last month, -0.95% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Ginkgo Bioworks Holdings (DNA) today, the total investment would be $ 934.00, based on the current price of $ 9.34.If past performance were to repeat, the return on your investment would be:In 1 year: $ 925.13In 5 years: $ 934.00In 10 years: $ 934.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Ginkgo Bioworks Holdings

Price

$ 9.34

return (12m)

-0.95%

p/e

-1.53

p/bv

0.93

DIVIDEND YIELD

0.00%

price DNA

DNA

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of DNA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

16.75%

3 months

-6.69%

1 year

-0.95%

2 years

-85.50%

5 years

0.00%

10 years

0.00%

Fundamentals DNA

review the fundamentals of Ginkgo Bioworks Holdings shares

P/E

-1.53

Sector: 7.58 Industry: 7.58

P/SALES RATIO (PSR)

2.87

Sector: 2.24 Industry: 2.24

P/BV

0.93

Sector: 1.93 Industry: 1.93

DIVIDEND YIELD (DY)

0.00%

Sector: 0.67% Industry: 0.67%

ROA

-28.55%

Sector: -0.78% Industry: -0.78%

ROE

-60.66%

Sector: 3.80% Industry: 3.80%

ROIC

-48.88%

Sector: -131.19% Industry: -131.19%

NET MARGIN

-100.00%

Sector: 1.44% Industry: 1.44%

GROSS MARGIN

72.71%

Sector: 30.26% Industry: 30.26%

OPERATING MARGIN

-100.00%

Sector: 3.25% Industry: 3.25%

P/EBITDA

-1.56

Sector: 2.22 Industry: 2.22

P/EBIT

-1.32

Sector: 0.24 Industry: 0.24

P/ASSET

0.44

Sector: 0.96 Industry: 0.96

BVPS

10.00

Sector: 9.05 Industry: 9.05

EPS

-6.06

Sector: 0.57 Industry: 0.57

EQUITY RATIO

0.47

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

31.83%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

36.20%

Sector: - Industry: -

Fundamentals DNA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
META	28.96	8.73	30.16%	0.31%	$ 1.69 T	30.89%
INTR	16.93	1.98	11.72%	0.97%	$ 3.63 B	15.47%
PBR	5.60	0.98	17.47%	16.22%	$ 78.17 B	16.15%
PLTR	394.43	64.60	16.38%	0.00%	$ 432.04 B	28.11%
VALE	10.01	1.30	13.01%	5.56%	$ 55.07 B	14.68%
SHEL	14.59	1.20	8.23%	3.88%	$ 213.41 B	5.44%
BDORY	10.26	0.66	6.40%	7.40%	$ 22.89 B	8.83%
STLA	2.97	0.41	13.77%	5.93%	$ 34.74 B	3.32%
MAIN	10.19	1.86	18.28%	6.95%	$ 5.47 B	86.13%
ENB	24.38	2.13	8.74%	5.61%	$ 104.88 B	9.40%
NSRGY	10.11	7.04	69.57%	3.48%	$ 251.33 B	11.75%
BBSEY	7.84	5.18	66.11%	11.79%	$ 12.44 B	100.00%
UNH	17.04	2.83	16.62%	2.60%	$ 299.80 B	4.04%
SAN	11.02	1.30	11.76%	1.92%	$ 167.13 B	22.61%
ITUB	10.53	1.94	18.42%	6.69%	$ 81.23 B	27.84%
TTE	10.21	1.23	12.05%	5.36%	$ 144.68 B	7.72%
PBR-A	5.19	0.91	17.47%	13.44%	$ 72.44 B	16.15%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

DNA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings

Average user rating I10

4.0 (2 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

The Company Ginkgo Bioworks Holdings (United States), is listed on Nasdaq with a market value of $ 518.00 Millions, having an equity of $ 559.78 Millions.

The Company is listedthe in the sector of Others and categorized in industry of Others.

In the last 12 months the Company had a revenue of $ 180.61 Millions, which generated a loss in the amount of $ -339.54 Millions.

As for its main indicators, the Company has a P/E ratio of -1.53, a P/BV ratio of 0.93 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker DNA.

Market cap

$ 518.00 Millions

Net worth

$ 559.78 Millions

US$ 559,780,000.00

Assets

$ 1.19 Billion

US$ 1,189,160,000.00

Total Shares Outstanding

56.00 Millions

56,000,000

Average Daily Trading Volume

$ 1.43 Million

US$ 1,427,152.88

Sector

Others

Industry

Others

DNA

DNA revenue and profits

Financial Results DNA

DRAG THE FRAME TO SEE MORE DATA

DNA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

VET - Vermilion Energy Inc.

$ 8.60 0,10% (12M)

P/E

-0.38

4.04%

DNA

Ginkgo Bioworks Holdings

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of DNA

review the fundamentals of Ginkgo Bioworks Holdings shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings

United States

- year

-

PROFIT X PRICE DNA

Financial Results DNA

DNA cash flow

asset growth - DNA

DNA balance sheet

VET - Vermilion Energy Inc.

UNH - UnitedHealth Group Incorporated

STLA - Stellantis NV

COR - Cencora Inc.

SSL - Sasol Ltd

SHEL - Shell PLC ADR

SSNLF - Samsung Electronics Co Ltd

CRERF - Carrefour SA

VET - Vermilion Energy Inc.

UNH - UnitedHealth Group Incorporated

STLA - Stellantis NV

COR - Cencora Inc.

SSL - Sasol Ltd

SHEL - Shell PLC ADR

SSNLF - Samsung Electronics Co Ltd

CRERF - Carrefour SA

Frequently Asked Questions